The safety of rosiglitazone in the treatment of Type 2 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The safety of rosiglitazone in the treatment of Type 2 diabetes

Published:2008-09 Issue:5 Volume:7 Page:579-585
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Singh Sonal¹²,Loke Yoon K³

Affiliation:

1. Assistant Professor Wake Forest University School of Medicine, Department of Medicine, Winston-Salem, NC 27103, USA

2. Wake Forest University School of Medicine, One Medical Center Boulevard, Section on General Internal Medicine, Winston-Salem, NC 27157, USA ; ;

3. Senior Lecturer in Clinical Pharmacology University of East Anglia, School of Medicine, Norwich, UK

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14740338.7.5.579

Reference37 articles.

1. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991–2004

2. Thiazolidinediones and Heart Failure

3. Long-term Risk of Cardiovascular Events With Rosiglitazone

4. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

5. Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicine Constitution Intervention Combined with "Three-in-One" Treatment in Elderly Patients with Atherosclerotic Cardiovascular and Cerebrovascular Diseases;American Journal of Health Behavior;2024-01-31

2. Meta-Analyses of Human Cell-Based Cardiac Regeneration Therapies;Circulation Research;2016-04-15

3. Critical Reading of an Article about Causation and Harm;World Family Medicine Journal/Middle East Journal of Family Medicine;2015-09

4. Discovery of P1736, a Novel Antidiabetic Compound That Improves Peripheral Insulin Sensitivity in Mice Models;PLoS ONE;2013-10-23

5. Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial;Circulation;2013-08-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3